ENTHEON BIOMEDICAL
Entheon is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective Dimethyltryptamine based psychedelic therapeutic products ("DMT Products") for the purposes of treating addiction and substance use disorders. Subject to obtaining all requisite regulatory approvals and permits, Entheon intends to generate revenue through the sale of its DMT Products to physicians, clinics and licensed psychiatrists in the United States, certain countries in the European Union and throughout Canada.
ENTHEON BIOMEDICAL
Industry:
Biopharma Biotechnology Health Care Life Science
Founded:
2010-04-06
Address:
Coquitlam, British Columbia, Canada
Country:
Canada
Website Url:
http://www.entheonbiomedical.com
Total Employee:
11+
Status:
Active
Contact:
604-562-3932
Total Funding:
3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Penn Medicine Co-Investment Program
Penn Medicine Co-Investment Program makes investments in faculty-driven cell therapy, gene therapy, and connected health companies
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-07-30 | Lobo Genetics | Lobo Genetics acquired by Entheon Biomedical | N/A |
| 2021-01-14 | HaluGen | HaluGen acquired by Entheon Biomedical | N/A |
Official Site Inspections
http://www.entheonbiomedical.com Semrush global rank: 5.69 M Semrush visits lastest month: 1.48 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Entheon Biomedical"
Entheon Biomedical
Intersecting established pharmacology with emerging medical technology, Entheon is developing a data-driven and comprehensive addiction recovery solution that personalizes patient care …See details»
Entheon Biomedical Corp. (ENBI.CN) - Yahoo Finance Canada
See the company profile for Entheon Biomedical Corp. (ENBI.CN) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Entheon Biomedical - Crunchbase Company Profile & Funding
Entheon is a addiction recovery solution that harnesses and optimizes the therapeutic potential of the DMT molecule.See details»
Entheon Biomedical - LinkedIn
Entheon Biomedical Pharmaceutical Manufacturing Vancouver, BC 1,676 followers Harnessing and optimizing the therapeutic potential of DMT to address the underlying mechanism of …See details»
Entheon Biomedical Company Description - Stock Analysis
Dec 4, 2024 Company profile for Entheon Biomedical Corp. (CSE: ENBI) with a description, list of executives, contact details and other key facts.See details»
Entheon Biomedical - Company Profile - Tracxn
Feb 25, 2025 Entheon Biomedical is a developer of psychedelic medicines for addiction disorders. The company has developed serotonin receptor modulating psychedelic molecules …See details»
Entheon Biomedica - Craft
Oct 29, 2024 Entheon Biomedica $250 k in annual revenue in FY 2023. See insights on Entheon Biomedica including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Entheon Biomedical | Psychedelic Invest
Entheon Biomedical is pioneering a leading-edge addiction recovery solution that harnesses and optimizes the therapeutic potential of the DMT molecule. Entheon exists to invert the addiction …See details»
Overview, News & Similar companies - ZoomInfo.com
View Entheon Biomedical (www.entheonbiomedical.com) location in British Columbia, Canada , revenue, industry and description. Find related and similar companies as well as employees …See details»
Entheon Biomedical Corp - CMOCRO
Entheon Biomedical is researching and developing psychedelic treatments using the DMT molecule as a benchmark upon which to improve drug safety and scalability. In addition, they …See details»
Entheon Biomedical Corp - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Entheon Biomedical Corp of Coquitlam, BC. Get the latest business insights from Dun & Bradstreet.See details»
Entheon Biomedical Corp (ENBI-CN) Profile - The Globe and Mail
See the company profile for Entheon Biomedical Corp (ENBI-CN) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Entheon Biomedical - VentureRadar
Cubed Biotech Inc Unknown Private Cubed Biotech is a Canadian company working to become a Health Canada licensed Contract Development & Manufacturing Organization. Subject to …See details»
Entheon Biomedical Corp. - The Canadian Securities Exchange (CSE)
May 3, 2018 The CSE provides a modern and efficient alternative for companies looking to access the Canadian public capital markets.See details»
Entheon Biomedical Corp. | CSE - Canadian Securities Exchange
Entheon is a biotechnology research and development company interested in treating addiction and substance use disorders.See details»
Entheon Biomedical Provides Update on Clinical and Preclinical …
Nov 24, 2021 Shipment of GMP DMT, In Vitro HERG and Genotox Assays Completed, and In Vivo Toxicity Assays Underway Vancouver, British Columbia–(Newsfile Corp. – November 24, …See details»
Entheon Biomedical - Psychedelic Alpha
Nov 12, 2020 Entheon Biomedical is a biotech company focussed on the development of psychedelic medicines for addiction disorders. The Company’s research and development …See details»
Entheon Biomedical Announces EEG Patent Application
Dec 16, 2021 Vancouver, British Columbia– (Newsfile Corp. – December 16, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“ Entheon ” or the “ Company …See details»
Entheon Biomedical Announces the Approval of DMT Clinical Trial
Feb 3, 2022 The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement. Neither the CSE nor the Investment Industry …See details»
Pantheon Vision and Eyedeal Medical enter collaborative …
13 hours ago Pantheon Vision has entered into a collaboration agreement with manufacturer Eyedeal Medical to advance the production and commercialization of Pantheon Vision’s …See details»